These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 16780024

  • 1. Pap smear screening in women under 30 in the Norwegian Coordinated Cervical Cancer Screening Program, with a comparison of immediate biopsy vs Pap smear triage of moderate dysplasia.
    Nygård JF, Nygård M, Skare GB, Thoresen SO.
    Acta Cytol; 2006; 50(3):295-302. PubMed ID: 16780024
    [Abstract] [Full Text] [Related]

  • 2. CIN 2/3 and cervical cancer after an ASCUS pap smear. A 7-year, prospective study of the Norwegian population-based, coordinated screening program.
    Nygård JF, Sauer T, Skjeldestad FE, Skare GB, Thoresen SØ.
    Acta Cytol; 2003; 47(6):991-1000. PubMed ID: 14674068
    [Abstract] [Full Text] [Related]

  • 3. Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program.
    Nygård JF, Nygård M, Skare GB, Thoresen SØ.
    Cancer Causes Control; 2005 May; 16(4):463-74. PubMed ID: 15953989
    [Abstract] [Full Text] [Related]

  • 4. Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap-smear in an opportunistic screening.
    Gram IT, Macaluso M, Stalsberg H.
    Acta Obstet Gynecol Scand; 1998 Feb; 77(2):228-32. PubMed ID: 9512333
    [Abstract] [Full Text] [Related]

  • 5. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.
    Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J.
    J Natl Cancer Inst; 2004 Feb 18; 96(4):280-93. PubMed ID: 14970277
    [Abstract] [Full Text] [Related]

  • 6. CIN 2/3 and cervical cancer in an organised screening programme after an unsatisfactory or a normal Pap smear: a seven-year prospective study of the Norwegian population-based screening programme.
    Nygård JF, Sauer T, Nygård M, Skare GB, Thoresen SØ.
    J Med Screen; 2004 Feb 18; 11(2):70-6. PubMed ID: 15153321
    [Abstract] [Full Text] [Related]

  • 7. 'Pap smear' for screening of precancerous conditions of cervix.
    Noreen R, Qudussi H.
    J Ayub Med Coll Abbottabad; 2011 Feb 18; 23(2):41-4. PubMed ID: 24800339
    [Abstract] [Full Text] [Related]

  • 8. [Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus].
    Bekkers RL, Hanselaar AG, Melchers WJ, van Schaik JH, Boonstra H, Massuger LF.
    Ned Tijdschr Geneeskd; 2003 Feb 15; 147(7):302-6. PubMed ID: 12622008
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A prospective evaluation of "see and treat" in women with HSIL Pap smear results: is this an appropriate strategy?
    Numnum TM, Kirby TO, Leath CA, Huh WK, Alvarez RD, Straughn JM.
    J Low Genit Tract Dis; 2005 Jan 15; 9(1):2-6. PubMed ID: 15870514
    [Abstract] [Full Text] [Related]

  • 12. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
    Subramaniam A, Fauci JM, Schneider KE, Whitworth JM, Erickson BK, Kim K, Huh WK.
    J Low Genit Tract Dis; 2011 Apr 15; 15(2):110-3. PubMed ID: 21263352
    [Abstract] [Full Text] [Related]

  • 13. A study of 10,296 pediatric and adolescent Papanicolaou smear diagnoses in northern New England.
    Mount SL, Papillo JL.
    Pediatrics; 1999 Mar 15; 103(3):539-45. PubMed ID: 10049953
    [Abstract] [Full Text] [Related]

  • 14. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
    Ferris DG, Wright TC, Litaker MS, Richart RM, Lorincz AT, Sun XW, Borgatta L, Buck H, Kramer L, Rubin R.
    J Fam Pract; 1998 Feb 15; 46(2):125-34. PubMed ID: 9487318
    [Abstract] [Full Text] [Related]

  • 15. Cervical neoplasia in pap smears: risk of cervical intra-epithelial neoplasia (CIN) after negative or no prior smears in a population without a mass screening programme.
    Forsmo S, Jacobsen BK, Stalsberg H.
    Int J Epidemiol; 1996 Feb 15; 25(1):53-8. PubMed ID: 8666505
    [Abstract] [Full Text] [Related]

  • 16. The borderline cervical smear: colposcopic and biopsy outcome.
    al-Nafussi A, Rebello G, al-Yusif R, McGoogan E.
    J Clin Pathol; 2000 Jun 15; 53(6):439-44. PubMed ID: 10911801
    [Abstract] [Full Text] [Related]

  • 17. Patients with negative cervical biopsies after papanicolaou test interpretations of "atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion": comparative longitudinal follow-up.
    Huitron S, Bonvicino A, Fadare O.
    Ann Diagn Pathol; 2008 Jun 15; 12(3):187-90. PubMed ID: 18486894
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Women's experience of coping with a positive Pap smear: A register-based study of women with two consecutive Pap smears reported as CIN 1.
    Ideström M, Milsom I, Andersson-Ellström A.
    Acta Obstet Gynecol Scand; 2003 Aug 15; 82(8):756-61. PubMed ID: 12848648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.